Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cristiano Fieni"'
Autor:
Cristiano Fieni, Carlo Sorrentino, Stefania Livia Ciummo, Antonella Fontana, Lavinia Vittoria Lotti, Sofia Scialis, Darien Calvo Garcia, Massimo Caulo, Emma Di Carlo
Publikováno v:
Experimental and Molecular Medicine, Vol 56, Iss 9, Pp 2033-2051 (2024)
Abstract The development of selective and nontoxic immunotherapy targeting prostate cancer (PC) is challenging. Interleukin (IL)30 plays immunoinhibitory and oncogenic roles in PC, and its tumor-specific suppression may have significant clinical impl
Externí odkaz:
https://doaj.org/article/2b604c52343746899661746bc5bde69f
Publikováno v:
MedComm, Vol 5, Iss 11, Pp n/a-n/a (2024)
Abstract Cancer is a leading cause of morbidity and mortality worldwide, and an increase in incidence is estimated in the next future, due to population aging, which requires the development of highly tolerable and low‐toxicity cancer treatment str
Externí odkaz:
https://doaj.org/article/abe5dea541064b628860ea070001b272
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-21 (2023)
Abstract Background Cancer-endothelial interplay is crucial for tumor behavior, yet the molecular mechanisms involved are largely unknown. Interleukin(IL)-30, which is expressed as a membrane-anchored cytokine by human prostate cancer (PC) cells, pro
Externí odkaz:
https://doaj.org/article/a11936ef8415464a9fa9597869814f9b
Autor:
Carlo Sorrentino, Luigi D’Antonio, Stefania Livia Ciummo, Cristiano Fieni, Lorena Landuzzi, Francesca Ruzzi, Simone Vespa, Paola Lanuti, Lavinia Vittoria Lotti, Pier Luigi Lollini, Emma Di Carlo
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-24 (2022)
Abstract Background Metastatic prostate cancer (PC) is a leading cause of cancer death in men worldwide. Targeting of the culprits of disease progression is an unmet need. Interleukin (IL)-30 promotes PC onset and development, but whether it can be a
Externí odkaz:
https://doaj.org/article/5f08df8435304f9e8d0e497d191bd3d7
Autor:
Carlo Sorrentino, Emma Di Carlo, Stefania Livia Ciummo, Luigi D'Antonio, Cristiano Fieni, Simone Vespa, Lavinia Lotti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background Progression of colorectal cancer (CRC), a leading cause of cancer-related death worldwide, is driven by colorectal cancer stem cells (CR-CSCs), which are regulated by endogenous and microenvironmental signals. Interleukin (IL)-30 has prove
Externí odkaz:
https://doaj.org/article/2df59bc60b24463fb7f2f840818edfd7
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Colorectal cancer (CRC) is one of the most common cancer worldwide, with a growing impact on public health and clinical management. Immunotherapy has shown promise in the treatment of advanced cancers, but needs to be improved for CRC, since only a l
Externí odkaz:
https://doaj.org/article/01117684a7e645b99b174db247448c0d
Autor:
Carlo Sorrentino, Paola Lanuti, Emma Di Carlo, Alice Turdo, Matilde Todaro, Stefania Livia Ciummo, Luigi D'Antonio, Cristiano Fieni
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/c7c2aa33d19743d48f3a0b54d1a785c6
Autor:
Stefania Livia Ciummo, Luigi D’Antonio, Carlo Sorrentino, Cristiano Fieni, Paola Lanuti, Giorgio Stassi, Matilde Todaro, Emma Di Carlo
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Breast cancer (BC) mortality is mainly due to metastatic disease, which is primarily driven by cancer stem cells (CSC). The chemokine C-X-C motif ligand-1 (CXCL1) is involved in BC metastasis, but the question of whether it regulates breast cancer st
Externí odkaz:
https://doaj.org/article/b9bc7a2a020e4ea6b56f7b136474e3c4
Autor:
Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Simone Vespa, Lavinia Lotti, Carlo Sorrentino, Emma Di Carlo
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006056
BackgroundProgression of colorectal cancer (CRC), a leading cause of cancer-related death worldwide, is driven by colorectal cancer stem cells (CR-CSCs), which are regulated by endogenous and microenvironmental signals. Interleukin (IL)-30 has proven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ce8e4c9227c8d25bd1bcd455a4a5a01
https://doi.org/10.1136/jitc-2022-006056
https://doi.org/10.1136/jitc-2022-006056
Autor:
Paola Lanuti, Carlo Sorrentino, Emma Di Carlo, Matilde Todaro, Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Alice Turdo
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
BackgroundBreast cancer (BC) progression to metastatic disease is the leading cause of death in women worldwide. Metastasis is driven by cancer stem cells (CSCs) and signals from their microenvironment. Interleukin (IL) 30 promotes BC progression, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e04ba58dbae3fd2854957158a025932
http://europepmc.org/articles/PMC8524378
http://europepmc.org/articles/PMC8524378